To investigate the effects of a in vivo 50 Hz/100 µT magnetic field exposure on rat lymphocytes.
Femal rats were continuously exposed to a magnetic field (50 Hz/ 100 µT) up to 13 weeks. After 2, 4, 8, and 13 weeks splenic lymphocytes were cultured to assess proliferation capacity of T- and B-lymphocytes, and interleukin 1 production. For this purpose lymphocytes were mitogen activated, concanavalin A and pokeweed mitogen were used for T- and B-lymphocytes, respectively.
Exposure | Parameters |
---|---|
Exposure 1:
50 Hz
Exposure duration:
continuous for 2 weeks.
|
|
Exposure 2:
50 Hz
Exposure duration:
continuous for 4 weeks.
|
|
Exposure 3:
50 Hz
Exposure duration:
continuous for 8 weeks.
|
|
Exposure 4:
50 Hz
Exposure duration:
continuous for 13 weeks.
|
|
Merritt et al.(1983)
Frequency | 50 Hz |
---|---|
Type | |
Waveform | |
Exposure duration | continuous for 2 weeks. |
Measurand | Value | Type | Method | Mass | Remarks |
---|---|---|---|---|---|
magnetic flux density | 100 µT | effective value | measured | unspecified | - |
Frequency | 50 Hz |
---|---|
Type | |
Waveform | |
Exposure duration | continuous for 4 weeks. |
Measurand | Value | Type | Method | Mass | Remarks |
---|---|---|---|---|---|
magnetic flux density | 100 µT | effective value | measured | unspecified | - |
Frequency | 50 Hz |
---|---|
Type | |
Waveform | |
Exposure duration | continuous for 8 weeks. |
Measurand | Value | Type | Method | Mass | Remarks |
---|---|---|---|---|---|
magnetic flux density | 100 µT | effective value | measured | unspecified | - |
Frequency | 50 Hz |
---|---|
Type | |
Waveform | |
Exposure duration | continuous for 13 weeks. |
Measurand | Value | Type | Method | Mass | Remarks |
---|---|---|---|---|---|
magnetic flux density | 100 µT | effective value | measured | unspecified | - |
The mitogenic responsiveness of B-lymphocytes as well as interleukin 1 production was not altered due to magnetic field exposure. However, T-lymphocytes exhibited a triphasic alteration during MF-exposure. Two weeks of MF-exposure leads to markedly enhanced mitogenic responsiveness, after 4 weeks less increased, after 8 weeks no differences to controls were observed, and after 13 weeks the mitogenic resposiveness was significantly decreased.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.